LIVE 11:25 am – 12:25 pm 4/27/2016 Disruptive Dozen Technologies: The Future of Cancer Therapies @2016 World Medical Innovation Forum: CANCER, April 25-27, 2016, Westin Hotel, Boston
2016 World Medical Innovation Forum: CANCER, April 25-27, 2016,
Partners HealthCare, Boston, at the Westin Hotel, Boston
ANNOUNCEMENT
Leaders in Pharmaceutical Business intelligence (LPBI) Group
Covering in Real Time using Social Media this Event on
CANCER Innovations
Aviva Lev-Ari, PhD, RN, Founder LPBI Group & Editor-in-Chief
http://pharmaceuticalintelligence.com
Streaming LIVE @Westin in Boston
worldmedicalinnovation.org
Novartis Ballroom
Disruptive Dozen
Cancer Faculty from the Brigham and Women’s Hospital, Massachusetts General Hospital, and Dana-Farber Cancer Institute nominated dozens of technologies that they believe will have the greatest impact on cancer care in the next decade. Senior Partners cancer leaders compiled the final list and ranking of these 12 disruptive technologies. A panel of experts will announce and discuss each of the technologies chosen. This intriguing, informative and fun session will let you in on how the experts view the future in their field.
50 Faculties of HMS – reviewed 100 selected 12 and ranked them
12. Nanotechnology and Cancer Treatment
- Delivery of Drugs: Doxil, Targeted therapies, paxil
- RNA
11. Refining Value in Cancer Care
- Better clinical trials
- Value and Outcome
- Pricing of oncology drugs will be a desruptive – moonshot is expensive
- Speed of bringing to market
10. Patient-Specific Research to Enable Efficient Drug Development
- computation genomics
- drug dosing
- Biopsy – functional genomics on this tissue
- microenvironment and immune therapy
- 3 weeks turn around, no biomarker,
- defined treatment choice on small scale to scale up
9. mHealth and Cancer Care
- mobile transmission of health data
- novel apps for navigation, support
- FDA predicts mobile apps will grow the fastest
- “Dr. Google”
- apps and platform to manage Care web-based technologies
- Manage survivorship care
- remove silos – patients carry their own Medical record – learning about it
- Outcomes for patients
8. Single-cell Molecular Profiling and RNA Sequencing
- tumor micro-environment
- desect the tumor
- capture cells for molecular analysis of ONE CELL
- microRNA, DNA, RNA
- earlier detection
7. CRISPR: Genome Editing and Cancer – Keith Joung, MD, PhD
- 2017 in the Clinic
- hit one place and no other
- quantify the risk and alteration occurring
- NEW class of therapeutics, safety evaluation
6. The Microbiome and Cancer – Lynn Bry, MD, PhD
- in cancer procarcinogenic
- microbe degrate metabolites
- mechanism the manipulate gene by bacteria
5. Epigenetics and Cancer Treatment – Johnathan Whetstine, PhD
- glioblastoma – proteins are joint targets
- genome stabilized or destabilized
- oncogenes
- mutations affecting genetic stability
- combinations in therapies per expressions
- RNA involved
4. Machine Learning & Computational Biology to Transform Cancer Care – AI – James Brink, MD
- integration of computational phynotupes, data dets genomics and other sources
Leave a Reply